Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer

Yunxia Huang,1,&ast; Yi Guo,2,&ast; Qin Xiao,3,&ast; Shuyu Liang,2 Qiang Yu,4 Lang Qian,1 Jin Zhou,1 Jian Le,1 Yuchen Pei,5 Lei Wang,4 Cai Chang,1 Sheng Chen,4 Shichong Zhou1 1Department of Ultrasonography, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan Universi...

Full description

Bibliographic Details
Published in:	Breast Cancer: Targets and Therapy
Main Authors:	Huang Y, Guo Y, Xiao Q, Liang S, Yu Q, Qian L, Zhou J, Le J, Pei Y, Wang L, Chang C, Chen S, Zhou S
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-07-01
Subjects:	triple-negative breast cancer radiomics somatic mutation signaling pathway
Online Access:	https://www.dovepress.com/unraveling-the-pivotal-network-of-ultrasound-and-somatic-mutations-in--peer-reviewed-fulltext-article-BCTT

Similar Items

Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer
by: Shuai Ge, et al.
Published: (2022-09-01)

Differentiating triple-negative breast cancer and atypical fibroadenomas using an ultrasound-based radiomics nomogram
by: Xinyu Zhu, et al.
Published: (2025-10-01)

Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences
by: Pedro Adolpho de Menezes Pacheco Serio, et al.
Published: (2021-12-01)

Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes
by: Cheng C, et al.
Published: (2025-01-01)

Analysis of the NLRP3 inflammasome components expression in triple-negative breast cancer patients with and without BRCA1 mutations
by: Sara Socorro Faria, et al.
Published: (2026-03-01)

Coding and regulatory somatic profiling of triple-negative breast cancer in Sub-Saharan African patients
by: Ricardo J. Pinto, et al.
Published: (2025-03-01)

Integrating ultrasound radiomics and clinicopathological features for machine learning-based survival prediction in patients with nonmetastatic triple-negative breast cancer
by: Wenwen, et al.
Published: (2025-02-01)

AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges
by: Zhihe Wang, et al.
Published: (2026-04-01)

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer
by: Kun Sun, et al.
Published: (2023-03-01)

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat EMT6 cell line-derived triple-negative breast cancer
by: Stephanie C. Pero, et al.
Published: (2026-04-01)

Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer
by: Yilin Chen, et al.
Published: (2025-03-01)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
by: Fan Y, et al.
Published: (2022-01-01)

Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
by: Ying Zhang, et al.
Published: (2022-06-01)

Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer
by: YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei
Published: (2022-09-01)

Mutation of BRCA1/2 Gene in Premenopausal Triple-Negative Breast Cancer Patients in West Sumatera
by: Wirsma Arif Harahap, et al.
Published: (2025-01-01)

Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
by: Wijden Mahfoudh, et al.
Published: (2019-04-01)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
by: Marco Santoro, et al.
Published: (2022-08-01)

Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01)

Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple‐negative breast cancer
by: Xia‐Bo Shen, et al.
Published: (2024-04-01)

Optimizing Triple-Negative Breast Cancer Therapy via Ultrasound-Enhanced Piezocatalysis for Targeted Chemodrug Release
by: Xue Q, et al.
Published: (2025-03-01)

A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer
by: Xiaomeng Jia, et al.
Published: (2022-12-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

Genetic risk and clinical implications of BRCA1 and BRCA2 mutations in Turkish triple-negative breast cancer patients
by: Betul Celik Demirbas, et al.
Published: (2025-09-01)

Results of immunohistochemistry diagnostics of breast cancer in the region of Grodno with consideration of the BRCA1 gene mutation in triple negative cancer
by: A. Yu. Krylov, et al.
Published: (2017-08-01)

Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
by: Hongwei Yu, et al.
Published: (2020-04-01)

Nanobioconjugate Trispecific Antibody Augments Antitumor Immunity of Triple Negative Breast Cancer
by: Chang Q, et al.
Published: (2026-06-01)

Radiomics for Detecting Metaplastic Histology in Triple-Negative Breast Cancer: A Step Towards Personalized Therapy
by: Rana Gunoz Comert, et al.
Published: (2025-09-01)

Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple‐negative breast cancer patients for potential biomarker development
by: Kunwar Somesh Vikramdeo, et al.
Published: (2023-10-01)

ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy
by: Zhou J, et al.
Published: (2023-03-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
by: Tong L, et al.
Published: (2023-08-01)

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
by: Chundi Gao, et al.
Published: (2021-04-01)

Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01)

A Machine-Learning Model for the Prediction of Triple-Negative Breast Cancer Based on Multiparameter MRI
by: Cai Y, et al.
Published: (2025-07-01)

Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Jiamin Guo, et al.
Published: (2024-06-01)

Diagnostic Value of Radiomics Analysis in Contrast-Enhanced Spectral Mammography for Identifying Triple-Negative Breast Cancer
by: Yongxia Zhang, et al.
Published: (2021-12-01)

Triple-negative breast cancer: Pattern of recurrence and survival outcomes
by: Shyny Reddy Chintalapani, et al.
Published: (2019-01-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
by: Magdalena Niedolistek, et al.
Published: (2020-04-01)

The latest developments in targeted therapy for triple-negative breast cancer
by: 刘子梅, et al.
Published: (2017-02-01)

Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
by: Nicole Brunetti, et al.
Published: (2023-01-01)